FILTER
FILTERED INTERVIEW RESULTS
Douglas Morrison
PRESIDENT & CEO, CENTRE FOR EXCELLENCE IN MINING INNOVATION (CEMI)
CEMI is supporting the future of the mining industry by encouraging innovation in the SME sector.
Chris Hodgson
PRESIDENT, ONTARIO MINING ASSOCIATION (OMA)
The Ontario Mining Association (OMA) has launched a social campaign, #ThisIsMining, to promote the benefits of the industry.
Jason Smith
GENERAL MANAGER, EPIROC CANADA
The automation revolution is here, and Epiroc is leading the way through its suite of innovative products.
Chris Stafford
PRESIDENT, C.J. STAFFORD & ASSOCIATES
C.J. Stafford & Associates is a boutique style executive search company that was established in 1981 and is recognized as specialists in recruiting for the Mining, Engineering and Construction industries.
Roy Slack
PRESIDENT, CANADIAN INSTITUTE OF MINING, METALLURGY AND PETROLEUM (CIM)
The CIM sees an opportunity to fill educational gaps within the mining industry and to support efforts to educate the wider public about the industry.
Dean McPherson
HEAD OF GLOBAL MINING, TORONTO STOCK EXCHANGE AND TSX VENTURE EXCHANGE
The TMX Group discusses how it maintains its dominance in the mining space.
Wayne Barnett
PRINCIPAL CONSULTANT (STRUCTURAL GEOLOGY), SRK CONSULTING
SRK Vancouver supports British Columbia and broader Canada with its range of services from exploration to reclamation.
Cathy Zhai
CEO, MONUMENT MINING
Monument Mining is Canadian company that aspires to become a mid-tier gold producer.
Guy Donatini & Marie Francine Poitras
CO-FOUNDER & PRESIDENT & MANAGER NORTH AMERICA, CORALIS
To serve its global client base better, CORALIS has opened offices in North America.
Normand Champigny
PRESIDENT & CEO, SPHINX RESOURCES
Sphinx discusses its shift in focus to a zinc project in southwestern Québec.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
